Fed. Circ. Casts Doubt On Bid To Revive Lung Drug IP Fight
Two judges in a Federal Circuit panel on Tuesday seemed unpersuaded by an argument from Roche unit Genentech Inc. that a Delaware federal judge wrongly let Sandoz Inc. off the hook...To view the full article, register now.
Already a subscriber? Click here to view full article